Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

Total global corporate funding for the sector stood at US$22.3 billion, down from US$28.9 billion at the same point in 2023.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

MRO Europe, the event for the commercial aviation aftermarket in the region, is set to provide an enhanced attendee ...

Scientists have created a global "superbug map," paving the way for scalable phage therapy to combat antibiotic-resistant infections in hospitals.

Forest defenders were stunned and concerned by the European Commission’s recent proposal for a 12-month delay in ...

US authorities have charged two Sudanese linked to DDoS cybercrime group, Anonymous Sudan, which caused $10m in damages ...

The European Parliament's new Development Committee chair argues Brussels' realpolitik policy is not set in stone — and maps ...

The Copernicus Sentinel Expansion Missions are a major leap forward in Europe's Earth observation capabilities. With the ...

Solar Flare Warning as Earth in Crosshairs of Explosive New Sunspot ...

Carbon has emerged as a third actor in the ongoing patent dispute between rival Chinese manufacturers JA Solar and Astronergy ...